<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04525365</url>
  </required_header>
  <id_info>
    <org_study_id>2017.019</org_study_id>
    <nct_id>NCT04525365</nct_id>
  </id_info>
  <brief_title>Pleural Suction Additional to Thoracostomy Tube for Traumatic Hemothorax</brief_title>
  <official_title>Pleural Suction and Evacuation in the Moment of Thoracostomy Tube Procedure in Traumatic Hemothorax Patients: A Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Pablo Tobón Uribe</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Pablo Tobón Uribe</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary treatment for traumatic hemothorax, is a thoracostomy tube. Some of these&#xD;
      patients develop a clotted hemothorax by insufficient drainage. This complication needs&#xD;
      surgical resolution and can generate an empyema. One strategy to reduce this complication is&#xD;
      pleural suction under sedation before the thoracostomy tube. The aim of the study is define&#xD;
      if the procedure really lower the incidence of clotted hemothorax. The investigators design&#xD;
      and open label, randomized, interventional study, comparing the realization of the pleural&#xD;
      suction and thoracostomy tube alone&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Traumatic hemothorax is a common emergency and is commonly the result of trauma, both blunt&#xD;
      and penetrating. Although closed drainage thoracostomy is commonly adequate for the initial&#xD;
      management of a hemothorax in most cases, failure of the closed thoracostomy and formation of&#xD;
      clotted hemothorax can occur in up to 5 to 30% of cases. This complication requires surgical&#xD;
      treatment and can generate an empyema, which is a serious infection.&#xD;
&#xD;
      Therefore, the investigators want to impact through a simple and low-cost procedure such as&#xD;
      traumatic hemothorax aspiration in the adult population, prior to insertion and fixation of&#xD;
      the thoracostomy tube under sedation, to evacuate all the hemothorax present, thus reducing&#xD;
      the formation of clots in these patients, and the probability of clotted hemothorax.&#xD;
&#xD;
      Methods: Initially, all patients with penetrating or closed chest trauma that came to the&#xD;
      emergency department, are evaluated clinically and with a chest x-ray. With this information,&#xD;
      the investigators diagnose patients with traumatic hemothorax or hemopneumothorax, and if is&#xD;
      a candidate for drainage with closed thoracostomy. The patient will receive a dose of&#xD;
      prophylactic antibiotic, which will be 2 gr of first-generation Cephalosporin, or 600mg iv of&#xD;
      Clindamycin for patients allergic to penicillin. At the time of performing the closed&#xD;
      thoracostomy procedure, and after approval and signing of the informed consent for the study&#xD;
      by the patient or his family member in charge, a consecutive number is assigned with prior&#xD;
      randomization of each of the groups in EPIDAT 4.0. In case of being an intervention group, a&#xD;
      superficial sedation of the patient will be carried out in the emergency department. Moderate&#xD;
      sedation or conscious sedation is performed. The pleura is opened and a sterile adult&#xD;
      Yankauer plastic suction cannula (Plus-vital, CE0197, Greetmed RPC) is inserted with closed&#xD;
      suction. The cannula will be directed towards the posterior costodiaphragmatic recess at&#xD;
      which point hemothorax aspiration will begin at -80 cubic centimeters of water (ccH2O) until&#xD;
      complete evacuation is achieved. At the end of the suction, the hemithorax cannula is removed&#xD;
      and a silicone 32 French (Fr) thoracostomy tube is inserted, which is subsequently fixed with&#xD;
      a non-absorbable 0-gauge suture. The chest tube is connected to a 3-bottle thoracic drainage&#xD;
      system ( Oasis Dry suction Water seal 3600 single collection) without continuous pleural&#xD;
      suction. After the procedure, a control chest X-ray will be performed within 3 hours to&#xD;
      verify the position of the tube, hemothorax drainage, and lung expansion. The clinical and&#xD;
      radiological follow up, will be made by surgeon criteria, until the patient develop a clotted&#xD;
      hemothorax or is discharged. The investigators will follow this patients by phone after a&#xD;
      month. Description and treatment of any adverse events will be made.&#xD;
&#xD;
      Analysis of each of the variables will be carried out in the two groups. Chi2 test to&#xD;
      establish statistical significance of these differences, with a bivariate analysis.&#xD;
&#xD;
      Registry of data will be made by the investigators, the source will be the clinical records,&#xD;
      and the month phone call, will be made by secondary investigators.&#xD;
&#xD;
      Sample size is of 250 participants, and is planned for 20 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 17, 2020</start_date>
  <completion_date type="Anticipated">July 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Pleural suction under sedation vs Tube Thoracostomy without pleural suction</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clotted hemothorax</measure>
    <time_frame>One month</time_frame>
    <description>Rate of clotted hemothorax found after Thoracostomy tube procedure or pleural aspiration procedure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Empyema</measure>
    <time_frame>One month</time_frame>
    <description>Rate of empyema found after Thoracostomy tube procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pleural aspiration procedure complications</measure>
    <time_frame>One month</time_frame>
    <description>Describe the percentage of patients with complications associated with the pleural aspiration procedure in patients scheduled for thoracostomy tube procedure</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Traumatic Hemothorax</condition>
  <arm_group>
    <arm_group_label>Pleural aspiration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pleural aspiration under sedation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Closed Thoracostomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Actual management</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pleural aspiration</intervention_name>
    <description>Pleural aspiration</description>
    <arm_group_label>Closed Thoracostomy</arm_group_label>
    <arm_group_label>Pleural aspiration</arm_group_label>
    <other_name>Closed Thoracostomy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Traumatic hemothorax that needs a Thoracostomy tube procedure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous hemothorax in the same hemithorax&#xD;
&#xD;
          -  Hemodynamic instability&#xD;
&#xD;
          -  Massive hemothorax&#xD;
&#xD;
          -  Obtaining saliva, bile, intestinal or gastric material, chyle at the time of&#xD;
             performing the procedure&#xD;
&#xD;
          -  Closed thoracostomy performed in other institution&#xD;
&#xD;
          -  Need of mayor surgical intervention in thorax&#xD;
&#xD;
          -  Contraindication for sedation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Willfredy Castano, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pablo Tobon Uribe Hospital, Thoracic Surgeon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Willfredy Castano, MD</last_name>
    <phone>(+57)3023749245</phone>
    <email>wcastano@hptu.org.co</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Salin Pereira, MD</last_name>
    <phone>(+57)3205244866</phone>
    <email>salinpwpw@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Pablo Tobon Uribe Hospital</name>
      <address>
        <city>Medellin</city>
        <state>Antioquia</state>
        <zip>050034</zip>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Willfredy Castano, MD</last_name>
      <phone>(+57)3023749245</phone>
      <email>wcastano@hptu.org.co</email>
    </contact>
    <contact_backup>
      <last_name>Jorge Donado, MSc</last_name>
      <phone>(+574)4459288</phone>
      <email>jdonado@hptu.org.co</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Colombia</country>
  </location_countries>
  <reference>
    <citation>Ramanathan R, Wolfe LG, Duane TM. Initial suction evacuation of traumatic hemothoraces: a novel approach to decreasing chest tube duration and complications. Am Surg. 2012 Aug;78(8):883-7.</citation>
    <PMID>22856496</PMID>
  </reference>
  <reference>
    <citation>Karmy-Jones R, Holevar M, Sullivan RJ, Fleisig A, Jurkovich GJ. Residual hemothorax after chest tube placement correlates with increased risk of empyema following traumatic injury. Can Respir J. 2008 Jul-Aug;15(5):255-8.</citation>
    <PMID>18716687</PMID>
  </reference>
  <reference>
    <citation>Bradley M, Okoye O, DuBose J, Inaba K, Demetriades D, Scalea T, O'Connor J, Menaker J, Morales C, Shiflett T, Brown C. Risk factors for post-traumatic pneumonia in patients with retained haemothorax: results of a prospective, observational AAST study. Injury. 2013 Sep;44(9):1159-64. doi: 10.1016/j.injury.2013.01.032. Epub 2013 Feb 19.</citation>
    <PMID>23433600</PMID>
  </reference>
  <reference>
    <citation>DuBose J, Inaba K, Demetriades D, Scalea TM, O'Connor J, Menaker J, Morales C, Konstantinidis A, Shiflett A, Copwood B; AAST Retained Hemothorax Study Group. Management of post-traumatic retained hemothorax: a prospective, observational, multicenter AAST study. J Trauma Acute Care Surg. 2012 Jan;72(1):11-22; discussion 22-4; quiz 316. doi: 10.1097/TA.0b013e318242e368.</citation>
    <PMID>22310111</PMID>
  </reference>
  <reference>
    <citation>Villegas MI, Hennessey RA, Morales CH, Londoño E. Risk factors associated with the development of post-traumatic retained hemothorax. Eur J Trauma Emerg Surg. 2011 Dec;37(6):583-9. doi: 10.1007/s00068-010-0064-3. Epub 2010 Dec 4.</citation>
    <PMID>26815469</PMID>
  </reference>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>June 11, 2020</study_first_submitted>
  <study_first_submitted_qc>August 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 25, 2020</study_first_posted>
  <last_update_submitted>November 30, 2020</last_update_submitted>
  <last_update_submitted_qc>November 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemothorax</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>We not consider to share the participant data by laws in our country</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 18, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/65/NCT04525365/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>August 18, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/65/NCT04525365/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

